Somatostatinoma
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
DEFINITION
- Rare neuroendocrine tumors (NETs) that arise primarily in the pancreas (from D cells) and duodenum.
- May or may not secrete excess somatostatin, called somatostatinoma syndrome.
- Somatostatin inhibits the secretion of endocrine hormones including insulin which contributes to development of diabetes as well as paracrine hormones including cholecystokinin, vasoactive intestinal peptide (VIP), gastric inhibitory polypeptide (GIP), and pancreatic polypeptide (PP).[17]
-- To view the remaining sections of this topic, please log in or purchase a subscription --
DEFINITION
- Rare neuroendocrine tumors (NETs) that arise primarily in the pancreas (from D cells) and duodenum.
- May or may not secrete excess somatostatin, called somatostatinoma syndrome.
- Somatostatin inhibits the secretion of endocrine hormones including insulin which contributes to development of diabetes as well as paracrine hormones including cholecystokinin, vasoactive intestinal peptide (VIP), gastric inhibitory polypeptide (GIP), and pancreatic polypeptide (PP).[17]
There's more to see -- the rest of this topic is available only to subscribers.